Proposed LCD DL40451: MolDX: Next-Generation Sequencing for Hematologic Malignancies and Suspected Hematologic Malignancies — CGS
Policy LCD-DL40451 · Oncology
Proposed NGS coverage rules for blood cancers in KY/OH — comments due 10/11/26
Code intelligence
0172U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0172U.
Critical code risk
Signal breakdown
5 shown · 5 total in platform
Risk: Critical
2
Critical
40%
3
High
60%
0
Routine
0%
0
Low
0%
New this month
+2
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Critical
Proposed LCD DL40425: MolDX: Next-Generation Sequencing for Hematologic Malignancies and Suspected Hematologic Malignancies — Palmetto GBA
Policy LCD-DL40425 · Oncology
Proposed LCD: NGS coverage criteria for blood cancers—comment by 10/11/26
LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Audit documentation
Building an audit file that includes 0172U?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription